Which company received FDA approval in 2021 for a CRISPR-based therapy for sickl

₹0.0

Question: Which company received FDA approval in 2021 for a CRISPR-based therapy for sickle cell disease?

Options:

Correct Answer: CRISPR Therapeutics

Solution:

CRISPR Therapeutics received FDA approval in 2021 for its CRISPR-based therapy, CTX001, aimed at treating sickle cell disease.

Which company received FDA approval in 2021 for a CRISPR-based therapy for sickle cell disease?

Which company received FDA approval in 2021 for a CRISPR-based therapy for sickle cell disease?

Step 1: Understand what CRISPR is - it's a technology used to edit genes.
Step 2: Know that sickle cell disease is a genetic condition that affects red blood cells.
Step 3: Learn that companies can develop therapies to treat diseases using CRISPR technology.
Step 4: Find out which company worked on a CRISPR therapy for sickle cell disease.
Step 5: Discover that CRISPR Therapeutics is the company that developed a therapy called CTX001.
Step 6: Check if CTX001 received FDA approval in 2021 for treating sickle cell disease.

No concepts available.